Ectopic fat in youth: The contribution of hepatic and pancreatic fat to metabolic disturbances

Obesity

Volumn 22, Issue 5, 2014, Pages 1280-1286

  Cohen, Michal ^a   Syme, Catriona ^a   Deforest, Meghan ^a   Wells, Greg ^a,b   Detzler, Garry ^a   Cheng, Hai Ling ^a,c   McCrindle, Brian ^a,b   Hanley, Anthony ^b   Hamilton, Jill ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; INSULIN;

ABDOMINAL ECTOPIC FAT; ADIPOSE TISSUE; ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FAT CONTENT; FEMALE; GLUCOSE METABOLISM; HEPATIC FAT; HUMAN; INSULIN METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID STORAGE; MALE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREATIC FAT; VISCERAL ECTOPIC FAT; ABDOMINAL FAT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; METABOLISM; PANCREAS; PATHOPHYSIOLOGY; SECRETION (PROCESS);

ABDOMINAL FAT; ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; PANCREAS;

EID: 84899897080     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20674     Document Type: Article

References (40)

1. Roberts KC, Shields M, de Groh M, et al. Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey. Health Rep 2012; 23: 37-41.
2. Weiss R,. Fat distribution and storage: how much, where, and how? Eur J Endocrinol 2007; 157 (Suppl 1): S39-S45.
3. Snijder MB, van Dam RM, Visser M, Seidell JC,. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
4. Kotronen A, Yki-Jarvinen H,. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 27-38.
5. Despres JP, Nadeau A, Tremblay A, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38: 304-309.
6. Roden M,. Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006; 2: 335-348.
7. Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999; 42: 113-116.
8. Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010; 26: 200-205.
9. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007; 30: 2916-2921.
10. Lingvay I, Esser V, Legendre JL, et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009; 94: 4070-4076.
11. Wicklow BA, Wittmeier KD, MacIntosh AC, et al. Metabolic consequences of hepatic steatosis in overweight and obese adolescents. Diabetes Care 2012; 35: 905-910.
12. Maggio AB, Mueller P, Wacker J, et al. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome. J Pediatr Gastroenterol Nutr 2012; 54: 720-726.
13. D'Adamo E, Cali AM, Weiss R, et al. Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010; 33: 1817-1822.
14. Larson-Meyer DE, Newcomer BR, Ravussin E, et al. Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children. Diabetologia 2011; 54: 869-875.
15. Denzer C, Thiere D, Muche R, et al. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009; 94: 3872-3881.
16. Perseghin G, Bonfanti R, Magni S, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006; 291: E697-E703.
17. Le KA, Mahurkar S, Alderete TL, et al. Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-kappaB stress pathway. Diabetes 2011; 60: 2802-2809.
18. Kovanlikaya A, Mittelman SD, Ward A, et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol 2005; 35: 601-607.
19. The WHO Child Growth Standards. Available at: http://www.who.int/ childgrowth/standards/en/.
20. Matsuda M, DeFronzo RA,. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
21. Retnakaran R, Shen S, Hanley AJ, et al. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 2008; 16: 1901-1907.
22. Retnakaran R, Qi Y, Goran MI, Hamilton JK,. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabetic Med J Br Diabetic Assoc 2009; 26: 1198-1203.
23. Bergman RN, Ader M, Huecking K, Van Citters G,. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51 (Suppl 1): S212-S220.
24. Sijens PE,. Parametric exploration of the liver by magnetic resonance methods. Eur Radiol 2009; 19: 2594-2607.
25. Cassidy FH, Yokoo T, Aganovic L, et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009; 29: 231-260.
26. Machann J, Thamer C, Schnoedt B, et al. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 2006; 55: 913-917.
27. Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009; 15: 1869-1875.
28. Cali AM, Caprio S,. Ectopic fat deposition and the metabolic syndrome in obese children and adolescents. Horm Res 2009; 71 (Suppl 1): 2-7.
29. Bennett B, Larson-Meyer DE, Ravussin E, et al. Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children. Obesity (Silver Spring). 2012; 20: 371-375.
30. DeFronzo RA, Gunnarsson R, Bjorkman O, et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest. 1985; 76: 149-155.
31. Manco M,. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. J Am Coll Nutr 2011; 30: 295-303.
32. Adiels M, Taskinen MR, Packard C, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006; 49: 755-765.
33. Musso G, Gambino R, Biroli G, et al. Am J Gastroenterol 2005; 100: 2438-2446.
34. Robertson RP, Harmon J, Tran PO, Poitout V,. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53 (Suppl 1): S119-S124.
35. Milburn JL, Jr,., Hirose H, Lee YH, et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995; 270: 1295-1299.
36. Del Prato SW, Gromada WJ, Schluchter BJ,. b-Cell mass plasticity in type 2 diabetes. Diabetes Obes Metab 2004; 6: 319-331.
37. Toledo-Corral CM, Alderete TL, Hu HH, et al. Ectopic fat deposition in prediabetic overweight and obese minority adolescents. J Clin Endocrinol Metab 2013; 98: 1115-1121.
38. Lee Y, Lingvay I, Szczepaniak LS, et al. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 2010; 34: 396-400.
39. Pinnick KE, Collins SC, Londos C, et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008; 16: 522-530.
40. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991; 156: 307-312.